Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate vs Delayed ART Initiation in HIV-Infected Children
NCT00234091Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2006
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of abacavir, efavirenz, lamivudine, lopinavir + ritonavir, nelfinavir in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2006; status: completed.
02
Drugs
abacavirefavirenzlamivudinelopinavir + ritonavirnelfinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00234091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234091.